VEGF and other canonical pro-angiogenic proteins (such as bFGF) have not been involved in the increased angiogenesis observed in GDM pathology and thus do not represent reliable candidates for early detection nor risk factors to develop GDM. The gene discussed is FGF2; the disease is gestational diabetes.